News and Announcements
Proteomics March Update: PromarkerD Progress, Indian Biotech Market Expansion & Solid Quarter Results
- Published April 26, 2016 11:48AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
26th April 2016, ASX Announcement
Life sciences company Proteomics International Laboratories Ltd (ASX:PIQ) (the Company, PILL) is pleased to provide the following update on its business activities for the three month period to 31 March 2016.
Highlights
- PromarkerD progress: 500 patient follow-up validation study underway to further validate PromarkerD’s initial ground-breaking results.
- IVD test kit for PromarkerD: Assessing development program to produce a clinical pathology In Vitro Diagnostic (IVD) test kit for PromarkerD.
- Therapeutic Drug Discovery Program: to discover new analgesic and antibiotics drug compounds.
- Analytical Services operations: Solid quarter-on-quarter results.
- Business Development: Company expands operations in massive Indian biotech market.
The March quarter delivered another period of sound performance for PILL. During the quarter, it embarked on a number of programs utilising its proprietary, disruptive technology platform. This included a development program, to produce a standard clinical pathology In Vitro Diagnostic (IVD) test kit for PromarkerD.
To view the full article, please click on the button below.
Company Updates
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation
For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]
Backed By Leading Investment Groups and Family Offices
